-
Talking About Disease-modifying Therapies for Parkinson’s (Webinar Audio)
September 24, 2025
… neurologist, scientist and medical director of the Barlo Multiple Sclerosis Program at St. Michael’s hospital. She is …
-
NBD Peptides in MPTP Pre-clinical Model
… markedly inhibit the neuroinflammatory disease process of multiple sclerosis (MS) in animals and attenuate the …
-
CSM-101 TRPML1 Agonist for Parkinson’s Disease
… is a molecularly-targeted drug with potential to treat multiple forms of PD. Given that the current treatment …
-
Chemical Modulator of Chaperone-mediated Autophagy in Parkinson's Disease
… Brain cells depend on very efficient surveillance systems to identify defective components and break them … to develop drugs to enhance the activity of this cleaning system as a possible future treatment for PD. This is an … obtained very promising results in cellular experimental system that have encouraged us to consider further …
-
Heiko Braak, MD, Honored with 2014 Robert A. Pritzker Prize
April 23, 2014
… Ulm University in Germany — outlined a Parkinson’s staging system, which describes the regional distribution and … process of Parkinson’s may begin in the peripheral nervous system before migrating to the brain. “Professor Braak’s … that alpha-synuclein aggregation could begin in the nervous system of the gastrointestinal tract and migrate from there …
-
Role of the JAK/STAT Pathway in Parkinson's Disease
… Our hypothesis is that monocytes and T-cells (immune system cells) from PD patients will exhibit heightened … PD, potentially in both the periphery and central nervous system, which may slow the neurodegenerative process. These …